Pathogenesis of bovine spongiform encephalopathy in sheep by Keulen, L.J.M., van et al.
ORIGINAL ARTICLE
Pathogenesis of bovine spongiform encephalopathy in sheep
L. J. M. van Keulen Æ M. E. W. Vromans Æ
C. H. Dolstra Æ A. Bossers Æ F. G. van Zijderveld
Received: 16 August 2007 / Accepted: 27 November 2007 / Published online: 19 December 2007
 The Author(s) 2007
Abstract The pathogenesis of bovine spongiform
encephalopathy (BSE) in sheep was studied by immuno-
histochemical detection of scrapie-associated prion protein
(PrPSc) in the gastrointestinal, lymphoid and neural tissues
following oral inoculation with BSE brain homogenate.
First accumulation of PrPSc was detected after 6 months in
the tonsil and the ileal Peyer’s patches. At 9 months
postinfection, PrPSc accumulation involved all gut-associ-
ated lymphoid tissues and lymph nodes as well as the
spleen. At this time point, PrPSc accumulation in the
peripheral neural tissues was first seen in the enteric ner-
vous system of the caudal jejunum and ileum and in the
coeliac-mesenteric ganglion. In the central nervous system,
PrPSc was first detected in the dorsal motor nucleus of the
nervus Vagus in the medulla oblongata and in the inter-
mediolateral column in the spinal cord segments T7–L1. At
subsequent time points, PrPSc was seen to spread within the
lymphoid system to also involve all non-gut-associated
lymphoid tissues. In the enteric nervous system, further
spread of PrPSc involved the neural plexi along the entire
gastrointestinal tract and in the CNS the complete neuraxis.
These findings indicate a spread of the BSE agent in sheep
from the enteric nervous system through parasympathetic
and sympathetic nerves to the medulla oblongata and the
spinal cord.
Introduction
Since the beginning of the epidemic of bovine spongiform
encephalopathy (BSE) in cattle in the UK in 1985, there
have been concerns about the possible spread of BSE to
other animal species including humans. These concerns
were later shown to be (at least partially) justified as BSE
has spread to wild and domestic cats and humans through
the consumption of meat or byproducts derived from BSE-
infected cattle [3, 4, 17]. In addition, BSE has spread to
wild herbivores and domestic goats, probably through the
ingestion of feed containing BSE-infected meat and bone
meal [3, 7].
There have been no reports of naturally occurring BSE
so far in sheep, although sheep are experimentally sus-
ceptible to BSE [8]. Naturally occurring BSE in sheep
could present a great danger to both humans and sheep.
Meat and byproducts from BSE-infected sheep would
present a greater danger to humans than products derived
from BSE-infected cattle because, in sheep, BSE infectiv-
ity is widespread through the whole lymphoid system (and
thereby the whole sheep carcass) [2, 9], in contrast to
cattle, where BSE infectivity is primarily limited to the
CNS [6, 9, 10]. Furthermore, BSE could theoretically
become endemic in the sheep population as has been
demonstrated in experimentally infected sheep flocks,
where BSE was seen to spread from ewe to lamb either in
utero or at birth [1]. This would mean that BSE in sheep
would be as difficult to eradicate as natural scrapie, where
all attempts at eradication so far have had limited effects.
Breeding programmes to select for sheep with PrP geno-
types associated with relative resistance to scrapie (and
BSE) have decreased the incidence of scrapie in affected
flocks, but it is still uncertain if these programmes will
eventually lead to the eradication of scrapie. The latter has
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been questioned by the appearance of atypical scrapie and
the successful intracerebral transmission of BSE to sheep
previously thought to be resistant to transmissible spongi-
form encephalopathies (TSEs) [5, 13].
Recently, the EU has stepped up the surveillance of
TSEs in small ruminants. Both slaughtered sheep or goats
and fallen stock are sampled for testing by one of the EU-
accredited TSE tests for small ruminants. In the case of a
positive result, further tests are done to discriminate BSE
from scrapie-infected animals. The small ruminant TSE
tests are all based on the detection of the scrapie-associ-
ated prion protein (PrPSc) in the obex of an infected sheep
or goat. The selection of the obex as sampling site is
largely based on our knowledge of the pathogenesis of
scrapie in sheep [20]. Whether the obex is as important in
the pathogenesis of BSE in sheep is unknown. Previous
studies by Bellworthy and others using both immunohis-
tochemistry and bio-assay in mice, have shown PrPSc and
infectivity to be widespread in viscera, lymphoid and
nervous tissues but did not clarify the pathogenesis of
BSE in sheep [2].
In the present study, we have followed up on our pre-
vious studies of natural scrapie in sheep. We have used a
similar approach combining a sequential time point study
with extensive histopathological and immunohistochemical
analysis of selected tissues to study the pathogenesis of
BSE in sheep. Although the immunohistochemical detec-
tion of scrapie-associated prion protein or PrPSc may not be
as sensitive as the detection of BSE infectivity through
mouse bio-assay, it does offer the great advantage of
identifying the cell types and neuro-anatomical pathway(s)
involved in the pathogenesis of BSE.
Materials and methods
Inoculation of sheep with BSE brain homogenate
The experimental infection of sheep with BSE brain
homogenate has been described previously (Table 1) [19].
In short, scrapie-free Texel or Texel cross ewes were bred
to produce offspring of the ARQ/ARQ and ARR/ARR
genotype (genotypes are expressed as the single letter
amino acid code present at codons 136, 154 and 171 of the
PrP gene). The PrP genotype of the lambs was checked by
full DNA sequencing of the open reading frame of the PrP
gene, and no other polymorphisms were detected. Eleven
lambs of the ARQ/ARQ genotype were orally dosed at the
age of 4–5 months with 5 g of a BSE brain homogenate
administered as 25 ml of a 20% brain homogenate in the
back of the mouth with a disposable syringe. The brain
homogenate was kindly provided by Dr. Martin Jeffrey and
was also used in previous BSE experiments in sheep in the
UK. The infectivity of the inoculum, as determined by
titration in RIII mice, was 103.97 log10 mouse intracerebral/
intraperitoneal LD50/g of tissue [2, 15]. The sheep were
housed in Biocontainment Level 3 facilities to constrain
any BSE infectivity spreading through the faeces and to
avoid any risk of cross-contamination with scrapie. One
ARQ/ARQ sheep was killed at 6, 9, 12, 13, 15, 17 and
19 months postinfection (mpi). Four sheep were left to
develop clinical disease and were killed for welfare reasons
once signs of ataxia were noticed. As negative controls,
one ARR/ARR lamb was orally infected with the same
dose of the BSE brain homogenate and one ARQ/ARQ
sheep was left uninoculated and housed separately from the
inoculated sheep.
Tissue sampling
Sheep were killed by intravenous injection of sodium
pentobarbital followed by exsanguination. Tissues were
sampled in duplicate (brain divided sagitally) with the
emphasis on the gastro-intestinal tract, the lymphoid tissues
including all gut-associated lymphoid tissues (GALT), the
brain, the spinal cord (C1–L6) and the autonomic ganglia.
Table 1 PrP genotypes of the sheep and the intervals at which they
were euthanised after oral dosing with BSE brain homogenate
Sheep
number
PrP
genotypea
Oral dosing
with 5 g
of BSE brainb
Killed at
(months
postinfection)
1 ARQ/ARQ + 6
2 ARQ/ARQ + 9
3 ARQ/ARQ + 12
4 ARQ/ARQ + 13
5 ARQ/ARQ + 15
6 ARQ/ARQ + 17
7 ARQ/ARQ + 19
8 ARQ/ARQ + 20c
9 ARQ/ARQ + 21c
10 ARQ/ARQ + 23c
11 ARQ/ARQ + 24c
12 ARQ/ARQ - 72
13 ARR/ARR + 72
a PrP genotype was determined by full-length DNA sequencing of the
open reading frame of the PrP gene and expressed as the single-letter
amino acid code present at codon 136, 154 and 171
b The BSE inoculum was administered as 25 ml of a 20% BSE brain
homogenate in the back of the mouth. The infectivity of the inoculum,
as determined by titration in RIII mice, was 103.97 log10 mouse
intracerebral/intraperitoneal LD50/g of tissue [2]
c Sheep with clinical signs of BSE, consisting of weight loss, pruritus
and tremor/ataxia
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One set of samples was fixed in phosphate-buffered for-
malin (pH 7) for 24 h, trimmed and fixed for another 24 h
before routine dehydration and processing into paraffin.
The other set of samples was stored at -70 C for future
biochemical analysis/bio-assay.
PrPSc immunohistochemistry
Tissue sections (4 lm) were deparaffinized in xylene and
decreasing gradients of ethanol while the endogenous
peroxidase activity was abolished with hydrogen peroxide
in methanol. Pretreatment of tissue sections consisted of
immersion for 30 min in formic acid followed by auto-
claving for 5 min in citrate solution (pH 6).
Immunostaining for the presence of PrPSc was performed
with the monoclonal 2G11 (Institut Pourquier, Montpellier,
France), which was raised against a synthetic peptide based
on the ovine PrP sequence 146–182. After extensive rins-
ing, sections were incubated with Mouse EnVisionTM HRP
(DakoCytomation, Glostrup, Denmark), followed by incu-
bation with diaminobenzidine containing 0.1 M imidazole.
Finally, sections were counterstained with haematoxylin,
dehydrated and permanently mounted. When PrPSc was
detected in a tissue for the first time, the entire tissue from
the animal of the previous kill was screened for the pres-
ence of PrPSc. For this purpose, the tissue block was
completely trimmed up into serial sections of 5 lm, and
multiple sections at 50-lm intervals were immunostained
for PrPSc.
Double immunohistochemistry
Double immunostaining was performed on lymphoid tis-
sues to identify PrPSc in cells of the macrophage/monocyte
lineage. PrPSc immunostaining was performed as described
above with the exception that Powervision AP (Immuno-
Vision technologies, Brisbane, CA, USA) was used as
secondary antibody and 5-bromo-4-chloro-3-indoxyl
phosphate and nitro blue tetrazolium chloride (BCIP/NBT
DakoCytomation, Glostrup, Denmark) were used as sub-
strate to develop an insoluble blue reaction product. After a
second autoclaving in citrate solution (pH 6) to destroy
mouse immunoglobulins from the first immunostaining,
sections were incubated with mouse anti-human CD68
(Clone Ki-M6, Serotec, Oxford, England), which recog-
nises an intracytoplasmic lysosomal-associated epitope
expressed by monocytes and macrophages. After rinsing,
sections were incubated with Mouse EnVisionTM HRP
(DakoCytomation, Glostrup, Denmark) and NovaREDTM
(Vector Laboratories, Burlingame, CA, USA) to develop
an insoluble red reaction product.
Results
One ARQ/ARQ sheep was sacrificed at each of the fol-
lowing time points after oral BSE inoculation: 6, 9, 12, 13,
15, 17 and 19 mpi. Four sheep were left to develop clinical
disease consisting of pruritus, weight loss, head tremor and
ataxia and were killed for welfare reasons once signs of
ataxia were noticed. Incubation times to terminal disease in
these four clinical BSE-infected sheep were 20, 21,23 and
24 mpi. Figure 1 schematically represents the progression
of the BSE infection in the ARQ/ARQ sheep as followed
by the immunohistochemical detection of PrPSc.
At 6 mpi (Fig. 1a), granules of PrPSc were detected in
single tingible body macrophages (TBMs) in the gut-
associated lymphoid tissues (GALT) of the palatine tonsil
(Fig. 2a) and the ileum (Fig. 2b). In the Peyer’s patches of
the ileum, PrPSc accumulation was very sparse and only
detected after thoroughly screening the entire tissue by
going through the entire paraffin block and examining
multiple sections every 50 lm. The same approach was
applied to other GALT tissues, the gastro-intestinal tissues,
the brain stem and the thoracic spinal cord, but no further
PrPSc accumulations were found.
At 9 mpi (Fig. 1b), PrPSc was readily detectable in a
number of GALT and GALT-draining tissues including the
tonsil, retropharyngeal lymph node, Peyer’s patches (jeju-
num, ileum and caecum), mesenteric lymph nodes and ileo-
caecal lymph node, and also in the spleen. The immuno-
staining was consistent with the previously described
accumulation of PrPSc at the follicular dendritic cells
(FDCs) and in TBMs (Fig. 3a). In addition, PrPSc was
found in the coeliac-mesenteric ganglion and in the sub-
mucosal and myenteric plexus of the enteric nervous
system (ENS) at the level of the caudal jejunum and ileum
(Fig. 3b). In the CNS, PrPSc accumulation was present in
the intermediolateral column (IMLC) of the spinal cord at
the level T7–L1 (Fig. 3c) and in the brain stem in the
ventral part of the dorsal motor nucleus of the nervus
Vagus (DMNV) at the level of the obex (Fig. 3d).
At 12–13 mpi (Fig. 1c), all lymphoid tissues including
the non-GALT tissues were positive for PrPSc (Fig. 4a). In
addition to the staining of FDCs and TBMs, single cells
within the cortical and subcortical sinuses of the lymph
nodes and in the marginal zone of the spleen were positive
for PrPSc. Double immunostaining for CD68 showed co-
localization of PrPSc in CD68-positive cells, indicating the
mononuclear phagocytic nature of these cells (Fig. 4b). In
the ENS, PrPSc accumulation was present from the level of
the mid-jejunum to the colon in the 12 months kill and in
the caudal jejunum and ileum in the 13 months kill. PrPSc
in the IMLC of the spinal cord had spread from segments
T2 to L4 and from segments T4 to T13, respectively
(Fig. 4c). In the DMNV, PrPSc was present throughout the
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entire length of the nucleus, with additional positive
staining in the area postrema in the sheep killed at 12 mpi
(Fig. 4d).
At 15 mpi (Fig. 1d), PrPSc in the ENS involved the
forestomachs at the level of the omasum and abomasum to
the colon. All segments of the spinal cord and most of the
Fig. 1 Schematic
representation of PrPSc
accumulation (in red) in the
lymphoid tissues, ENS and CNS
of ARQ/ARQ sheep orally
infected with BSE after a
6 months b 9 months c 12–
13 months d 15 months e
17 months and f 19 months and
after the onset of clinical
disease. Abbreviations: DMNV
dorsal motor nucleus of the
vagus; IMLC intermediolateral
column; C, T and L cervical,
thoracic and lumbal segments of
the spinal cord; GN ganglion
nodosus; GMCC ganglion
mesentericum cranialis/
coeliacum; GS ganglia spinalis;
O oesophagus; R rumen; Re
reticulum; Om omasum; Ab
abomasum; Du duodenum; Je
jejunum; Il ileum; Ca caecum;
Co colon; Rec rectum; GALT
gut-associated lymphoid tissues;
GALT Lnn lymph nodes
draining from GALT tissues.
Only the efferent motor fibers of
the autonomic nervous system
are shown
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spinal ganglia were positive for PrPSc. In the brain, PrPSc
accumulation was seen throughout the medulla oblongata
and was sparsely seen in some neurons in the pons.
At 17 mpi (Fig. 1e), PrPSc was detected in the ENS from
the omasum to the colon. In the CNS, PrPSc was seen in the
entire brain stem and in the hypothalamic and thalamic
area. All spinal ganglia from the cervical, thoracic and
lumbal spinal cord segments were positive for PrPSc at
17 mpi. Prominent vacuolation was present both in the
neuropil and within neurons of the DMNV at the obex.
From 19 mpi and in the four clinically affected sheep
(Fig. 1f), PrPSc had spread to involve the entire ENS from
Fig. 1 continued
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oesophagus to rectum. PrPSc was detected at all levels in
the CNS including cerebellum, basal ganglia and cerebral
cortex and in the spinal cord.
The BSE-challenged ARR/ARR sheep and the negative
control ARQ/ARQ sheep showed no clinical signs of BSE
during the course of the experiment and were euthanised at
72 mpi (Table 1). No PrPSc was detected by immunohis-
tochemistry or Western blotting in the tissues collected
from these sheep.
Discussion
In this study, we investigated the pathogenesis of a BSE
infection in sheep by following the accumulation of PrPSc
in sheep killed at various time points during the incubation
period of BSE. The first tissues to accumulate PrPSc were
the lymphoid tissues of the GALT, followed by the GALT-
draining lymph nodes and the spleen and, at a later stage,
the non-GALT lymph nodes. The temporal spread and
pattern of PrPSc deposition in the lymphoid tissues were
similar to those described previously for natural scrapie
[21, 22]. In the spleen of the BSE-infected sheep, however,
a more abundant accumulation of PrPSc was seen in mac-
rophages of the marginal zone. This probably reflects an
active trapping and phagocytosis of PrPSc during a sys-
temic circulation of the BSE agent. This is in agreement
with the studies of Houston et al., who demonstrated the
presence of infectivity in the blood of orally BSE-infected
sheep, both in the preclinical and clinical phase, by the
transmission of BSE to TSE-free recipients through whole-
blood transfusion [12, 14]. The question remains which
fraction of the blood contains BSE infectivity and thus
whether the BSE agent is present in blood plasma or
whether it is associated with a cellular component of the
blood. Preliminary results from transfusion with blood
fractions have shown infectivity in the buffy coat but could
not exclude infectivity in plasma and/or red cell fractions
[14].
The first peripheral nervous tissues to accumulate PrPSc
in the pathogenesis of BSE in sheep were the post-gan-
glionic parasympathetic motor neurons in the submucosal
and myenteric plexi of the ENS and the post-ganglionic
sympathetic motor neurons in the coeliac-mesenteric gan-
glion. The first accumulations of PrPSc in the CNS were
detected in the pre-ganglionic parasympathetic motor
neurons of the DMNV in the brain stem and in the pre-
ganglionic sympathetic motor neurons of the IMLC in the
spinal cord. From these initial sites of PrPSc accumulation
in the peripheral and central nervous system, PrPSc sub-
sequently spread to involve the entire ENS and CNS. This
pathogenetic route of the BSE agent from the ENS through
the efferent motor fibers of the autonomic nervous system
to the CNS is similar to the pathogenesis of natural scrapie
in sheep [20]. In scrapie- and BSE-infected sheep, the
preceding infection of the Peyer’s patches could possibly
play a role in facilitating the infection of the post-gangli-
onic motor neurons of the ENS. In cattle orally exposed to
BSE, infectivity has also been found in the Peyer’s patches
of the ileum [23, 24]. Preliminary observations on the
pathogenesis of BSE in cattle indicate a similar spread of
the BSE agent from the gut through the efferent autonomic
nervous system to the CNS [11]. However, the role of the
ENS in the pathogenesis of BSE in cattle is still obscure as
PrPSc was not found in the ENS during the early stages of a
BSE infection and only sparsely in the myenteric plexus of
cattle in the end stage of BSE [18].
The results of the present study can be compared with
previous time course studies on BSE in sheep in which the
same dose and the same BSE brain homogenate were used
for oral inoculation of ARQ/ARQ Romney sheep. In these
studies, infectivity was detected by bio-assay in RIII mice
Fig. 2 BSE-infected sheep 6 months after oral inoculation. PrPSc
immunostaining of a palatine tonsil and b Peyer’s patches of the
ileum. PrPSc accumulations are present in tingible body macrophages
of the lymphoid follicles. Bar 50 lm
450 Arch Virol (2008) 153:445–453
123
in the Peyer’s patches at 4 mpi [2]. In contrast, at this time
point, PrPSc was detected immunohistochemically only in
the retropharyngeal lymph node and not in the Peyer’s
patches [2, 15]. In our study of ARQ/ARQ Texel sheep, we
detected sparse deposits of PrPSc at 6 mpi in both the tonsil
and Peyer’s patches that were only detected after thorough
Fig. 4 BSE-infected sheep
12 months after oral
inoculation. PrPSc
immunostaining in a the Peyer’s
patches of the ileum b marginal
zone in the spleen c IMLC of
the spinal cord segment T5 and
d DMNV at the obex . Note the
colocalization of PrPSc (blue)
and marginal zone macrophages
(red) in the inlay in b (arrow).
CA central arteriole; GC
germinal center; MZ marginal
zone. a Bar 100 lm; b bar
100 lm; c bar 500 lm; d bar
500 lm
Fig. 3 BSE-infected sheep 9 months after oral inoculation. PrPSc
immunostaining in a the Peyer’s patches of the ileum b the myenteric
plexus of the ileum c IMLC of the spinal cord segment T10 and d
DMNV at the obex. Note the sparse neuronal cell labelling in the
IMLC (inlay in c) and the ventral part of the DMNV (inlay in d). a
Bar 50 lm; b bar 20 lm; c and d bar 500 lm
Arch Virol (2008) 153:445–453 451
123
screening of the entire tissue by examining sections every
50 lm until the blocks were exhausted. This might explain
the difference with the immunohistochemical studies in the
Romney sheep where PrPSc was only detected in the ret-
ropharyngeal lymph node, but it is in general agreement
with the bio-assay, where infectivity was found in the Pe-
yer’s patches at 4 mpi (but not in the tonsil). In the Texel
sheep killed at 9 mpi, all GALT tissues, the spleen, ENS,
IMLC and DMNV were positive for PrPSc, whereas in the
Romney sheep at 10 mpi, PrPSc was only detected in the
retropharyngeal lymph node, and infectivity was only
detected in the spleen. This indicates a more rapid spread
of the BSE infection in the Texel sheep compared to the
Romney sheep, since both the dose and the inoculum were
the same in the two studies. Because the age at inoculation
and the PrP genotypes of the animals in both studies were
also the same, the differences in the temporal spread of the
BSE agent between the two breeds must be related to other
genetic factors outside the PrP region, or to other unknown
breed factors. In the Romney sheep, the BSE agent only
became widespread at 16 mpi when PrPSc and infectivity
were detected in a wide range of nervous tissues, lym-
phoreticular tissues and viscera including the liver. PrPSc in
the liver was reported to be present within Kupffer cells at
several stages of the BSE infection (M. Jeffrey, personal
communication). In the Texel sheep however, no PrPSc was
detected in Kupffer cells or hepatocytes at any stage during
the BSE infection.
At present, active surveillance of TSE in sheep and
goats has been increased in the EU (EU regulation 214/
2005) because of the finding of a BSE-infected goat in
France [7] and possibly in the UK (confirmation by strain
typing is still pending) [16]. Several rapid tests for TSEs in
small ruminants are now available (EU regulation 260/
2005), all of which use the medulla oblongata, and in
particular, the obex region as source material for testing. In
the present study, we detected PrPSc in the DMNV at the
obex of BSE-infected sheep from 9 mpi. In a previous
study of natural scrapie in sheep, PrPSc was detected in the
DMNV in sheep from 10 months of age [20]. Therefore,
preclinically TSE-infected animals are likely to be identi-
fied through rapid testing as long as the DMNV region in
the obex is excised and used for rapid testing. Further
biochemical and/or immunohistochemical tests can then be
used to differentiate BSE from scrapie infection, while final
confirmation of the TSE strain will still require bio-assay in
mice.
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